Cargando…
Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
Discoidin, CUB, and LCCL domain-containing protein 2 (DCBLD2) is a two-domain transmembrane protein-coding gene located on chromosome 3, the protein expressed by which acts as the membrane receptor of semaphorin and vascular endothelial growth factor during the development of axons and blood vessels...
Autores principales: | Xie, Pan, Liu, Jun-Yan, Yan, Han, Wang, Zhi-Bin, Jiang, Shi-Long, Li, Xi, Liu, Zhao-Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403722/ https://www.ncbi.nlm.nih.gov/pubmed/36034778 http://dx.doi.org/10.3389/fphar.2022.950831 |
Ejemplares similares
-
Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021) -
Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
por: Li, Lingqin, et al.
Publicado: (2023) -
Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023) -
Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment
por: Xue, Xin-miao, et al.
Publicado: (2022) -
Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
por: Zhou, Libo, et al.
Publicado: (2023)